“Programmed Polymeric Devices” for Pulsed Drug Delivery

Pharmaceutical research strives to design drug delivery systems that respond to therapeutic needs. Considering the facts that physiologic parameters (e.g., heart rate, blood pressure, and plasma concentration of hormones, plasma proteins, and enzymes) display constancy over time, drug delivery systems with a constant release profile have been designed. However, because of circadian rhythms in physiologic parameters and pathologic conditions (e.g., asthma, angina pectoris), the conventional paradigm concerning drug concentrations “the flatter the better” may not be what the organism may need. Instead, to correlate with our biological needs, “precisely timed drug delivery,” which could be accomplished with “programmable dosage forms,” is required. Precisely timed drug delivery may maximize therapeutic efficacy, may minimize dose frequency, and may reduce toxicity by avoiding side effects and drug tolerance. This paper outlines the concepts that have been proposed to release drugs in a pulsed manner from pharmaceutical devices.

[1]  J L Cleland,et al.  Development of a single-shot subunit vaccine for HIV-1. 5. programmable in vivo autoboost and long lasting neutralizing response. , 1998, Journal of pharmaceutical sciences.

[2]  S. Mitragotri,et al.  Frequency Dependence of Sonophoresis , 2001, Pharmaceutical Research.

[3]  J. Heller,et al.  Pulsatile and delayed release of lysozyme from ointment-like poly(ortho esters) , 1992 .

[4]  W. Hennink,et al.  Delayed release of a model protein from enzymatically-degrading dextran hydrogels , 1997 .

[5]  N. Yui,et al.  Pulsatile peptide release from multi-layered hydrogel formulations consisting of poly(ethylene glycol)-grafted and ungrafted dextrans. , 1999, Journal of biomaterials science. Polymer edition.

[6]  T. Wrin,et al.  Development of a single-shot subunit vaccine for HIV-1. 3. Effect of adjuvant and immunization schedule on the duration of the humoral immune response to recombinant MN gp120. , 1996, Journal of pharmaceutical sciences.

[7]  M. Brandon,et al.  In vitro testing of a pulsatile delivery system and its in vivo application for immunisation against tetanus toxoid , 1997 .

[8]  T. Okano,et al.  Time-programmed pulsatile release of dextran from calcium-alginate gel beads coated with carboxy-n-propylacrylamide copolymers. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[9]  N. Yui,et al.  Hyaluronic acid grafted with poly(ethylene glycol) as a novel peptide formulation. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[10]  K. Zhu,et al.  Pulsatile protein release from a laminated device comprising polyanhydrides and pH-sensitive complexes. , 2000, International journal of pharmaceutics.

[11]  B. Gander,et al.  Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. , 1996, Vaccine.

[12]  E. Edelman,et al.  Optimization of release from magnetically controlled polymeric drug release devices. , 1993, Biomaterials.

[13]  Y. Tokunaga,et al.  In vivo performance of time-controlled explosion system (TES) in GI physiology regulated dogs , 1998 .

[14]  T. Park,et al.  Determinants of Release Rate of Tetanus Vaccine from Polyester Microspheres , 1993, Pharmaceutical Research.

[15]  J. Heller Modulated release from drug delivery devices. , 1993, Critical reviews in therapeutic drug carrier systems.

[16]  M. Lawrence,et al.  Formulation of electrically conducting microemulsion-based organogels. , 2003, International journal of pharmaceutics.

[17]  A. D'emanuele,et al.  On-off transport through a thermoresponsive hydrogel composite membrane. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Hans P. Merkle,et al.  Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres : importance of polymer degradation and antigen release for immune response , 1996 .

[19]  Sakurai Yasuhisa,et al.  Regulated release of drug microspheres from inflammation responsive degradable matrices of crosslinked hyaluronic acid , 1993 .

[20]  R K Gupta,et al.  Pulsed controlled-released system for potential use in vaccine delivery. , 1996, Journal of pharmaceutical sciences.

[21]  B. Gander,et al.  A contribution to overcoming the problem of residual solvents in biodegradable microspheres prepared by coacervation , 1996 .

[22]  K. Zhu,et al.  Design of a core-shelled polymer cylinder for potential programmable drug delivery. , 2001, International journal of pharmaceutics.

[23]  Donald L. Wise,et al.  Design of capsules that burst at predetermined times by dialysis , 1992 .

[24]  J L Cleland,et al.  Development of a single-shot subunit vaccine for HIV-1. 2. Defining optimal autoboost characteristics to maximize the humoral immune response. , 1996, Journal of pharmaceutical sciences.

[25]  Sakurai Yasuhisa,et al.  Inflammation responsive degradation of crosslinked hyaluronic acid gels , 1992 .

[26]  W. Hennink,et al.  Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[27]  R. Langer,et al.  Enzymatically activated microencapsulated liposomes can provide pulsatile drug release , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  S. Schwendeman,et al.  Stabilization of Proteins Encapsulated in Cylindrical Poly(lactide-co-glycolide) Implants: Mechanism of Stabilization by Basic Additives , 2000, Pharmaceutical Research.

[29]  J L Cleland,et al.  Development of a single-shot subunit vaccine for HIV-1. , 1997, AIDS research and human retroviruses.

[30]  Ronald A Siegel,et al.  New mode of drug delivery: long term autonomous rhythmic hormone release across a hydrogel membrane. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Richard W. Baker,et al.  Osmotic drug delivery : a review of the patent literature , 1995 .

[32]  A. Göpferich,et al.  Programmable biodegradable implants. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[33]  Wim E. Hennink,et al.  Controlled Release of Liposomes from Biodegradable Dextran Microspheres: A Novel Delivery Concept , 2000, Pharmaceutical Research.

[34]  F. Horkay,et al.  Swelling Pressure Observations on Degrading Dex-HEMA Hydrogels , 2002 .

[35]  R. Baker,et al.  Controlled Release Delivery Systems , 1986 .

[36]  R Langer,et al.  Responsive polymeric delivery systems. , 2001, Advanced drug delivery reviews.

[37]  D Needham,et al.  Lipid-coated microgels for the triggered release of doxorubicin. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[38]  A. Göpferich,et al.  Bioerodible implants with programmable drug release , 1997 .

[39]  F. Patat,et al.  Effect of sonication parameters on transdermal delivery of insulin to hairless rats. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[40]  T. Okano,et al.  Effect of Ca2+-alginate gel dissolution on release of dextran with different molecular weights. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[41]  T. Uchida,et al.  Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres. , 1996, Chemical & pharmaceutical bulletin.

[42]  A. Straughn,et al.  Pharmacokinetics of Methylphenidate After Oral Administration of Two Modified-Release Formulations in Healthy Adults , 2003, Clinical pharmacokinetics.

[43]  Ajay K Banga,et al.  Electrically enhanced transdermal delivery of a macromolecule , 2002, The Journal of pharmacy and pharmacology.

[44]  J. Kost Pulsed and Self-Regulated Drug Delivery , 1990 .

[45]  T. Aminabhavi,et al.  Stimulus-Responsive “Smart” Hydrogels as Novel Drug Delivery Systems , 2002, Drug development and industrial pharmacy.

[46]  Michael R Powell Drug Delivery Issues in Vaccine Development , 1996, Pharmaceutical Research.

[47]  R. Langer,et al.  Predicting drug release from cylindric polyanhydride matrix discs , 1995 .

[48]  S. Tanna,et al.  A Covalently Stabilised Glucose Responsive Gel Formulation with a Carbopol ® Carrier , 2002, Journal of drug targeting.

[49]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[50]  A. Göpferich,et al.  Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.

[51]  J. Mcghee,et al.  Biodegradable microspheres as a vaccine delivery system. , 1991, Molecular immunology.

[52]  Walter J. Murphy CHEMICAL AND ENGINEERING NEWS: State Science , 1948 .

[53]  W. Hennink,et al.  Controlled release of a model protein from enzymatically degrading dextran microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[54]  S. Ueda,et al.  Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. , 1994, Journal of drug targeting.

[55]  F. Horkay,et al.  Tailoring the swelling pressure of degrading dextran hydroxyethyl methacrylate hydrogels. , 2003, Biomacromolecules.